IWF vs SCHX: 56% overlap
iShares Russell 1000 Growth ETF and Schwab U.S. Large-Cap ETF share 56.5% of their portfolios by weight — computed as Σ min(wA, wB) over every holding both funds own.
Different holding dates. These holdings were published about 2 months apart — SCHX as of 2026-05-31, the rest through 2026-07-23. Each fund is compared using its most recent file, so any trading in between shows up as a difference.
You would hold two tickers and get the diversification of 1.4. Two funds that shared nothing would score 2.0; two identical funds score 1.0.
Top shared holdings
IWF and SCHX hold 252 of the same securities. The ten contributing most to the overlap figure:
| Holding | in IWF | in SCHX | Δ |
|---|---|---|---|
| NVDA | 15.1% | 7.5% | 7.6% |
| AAPL | 7.8% | 6.7% | 1.1% |
| MSFT | 4.4% | 4.9% | 0.5% |
| GOOGL | 5.7% | 3.2% | 2.5% |
| AVGO | 5.7% | 3.1% | 2.6% |
| GOOG | 4.7% | 2.6% | 2.1% |
| META | 3.4% | 2.0% | 1.4% |
| TSLA | 2.9% | 1.8% | 1.1% |
| MU | 3.5% | 1.6% | 1.9% |
| LLY | 2.9% | 1.3% | 1.7% |
Where IWF and SCHX differ
Sector weights as a share of each fund, ordered by the size of the gap rather than the size of the sector — two funds that overlap heavily still usually diverge somewhere.
| Sector | IWF | SCHX | Δ |
|---|---|---|---|
| Information Technology | 55.0% | 36.8% | +18.2pp |
| Financials | 4.7% | 10.9% | −6.2pp |
| Communication Services | 15.7% | 10.1% | +5.6pp |
| Unclassified | 0.0% | 3.4% | −3.4pp |
| Consumer Staples | 1.3% | 4.4% | −3.1pp |
| Energy | 0.5% | 3.2% | −2.6pp |
| Health Care | 5.6% | 8.1% | −2.6pp |
| Consumer Discretionary | 7.5% | 9.4% | −1.9pp |
Δ is IWF minus SCHX, in percentage points. Sector data is not published by every issuer, so “Unclassified” is a real category rather than a gap in the table.
What each fund holds alone
4.3% of IWF by weight, held in no part of SCHX.
34.0% of SCHX by weight, held in no part of IWF.
A large count with a small weight is the usual shape: the positions one fund adds are typically its smallest ones.
Concentration and cost
| IWF | SCHX | |
|---|---|---|
| Top 10 holdings | 56.1% | 37.3% |
| Positions held | 370 | 750 |
| Cost per $10,000 held, per year | $19 | $3 |
Cost is the expense ratio applied to $10,000; it excludes any brokerage commission, bid-ask spread or tax consequence. Figures are facts about the funds, not a suggestion about which to hold.
Frequently asked
How much do IWF and SCHX overlap?
IWF and SCHX overlap 56.5% by portfolio weight — substantial duplication if you hold both. They share 252 holdings. The figure comes from current issuer holdings files (IWF as of 2026-07-23, SCHX as of 2026-05-31).
How is the overlap between IWF and SCHX calculated?
As the sum of the smaller weight in each fund, over every holding both funds own: Σ min(wA, wB). If IWF holds a stock at 6% and SCHX holds the same stock at 4%, 4% counts as shared. The result is bounded between 0% and 100%, and it is computed after looking through any fund-of-funds to the underlying holdings.
Is it redundant to hold both IWF and SCHX?
That depends on your goals — we state facts, not advice. At 56.5% overlap, each fund still contributes meaningfully distinct exposure.
What does IWF own that SCHX doesn't?
IWF holds 370 positions and SCHX holds 750; 117 of IWF's positions don't appear in SCHX at all, and they are 4.3% of IWF by weight.
You probably hold more than two funds
This page compares IWF and SCHX. Paste your whole portfolio — brokerage, 401(k), IRA — and see the overlap across every fund at once, plus what you actually own underneath them and your own Effective Funds number. Free, no account, nothing stored.
X-ray my portfolio — free →Watch IWF vs SCHX
We re-read both funds’ published holdings every weeknight. Leave an address and we'll tell you when what's inside actually changes.
Not sending yet — email alerts are built but switched off, and you'll be among the first when they turn on. No spam, one-click unsubscribe.
Related comparisons
Sources: issuer holdings files, IWF as of 2026-07-23, SCHX as of 2026-05-31. Weights are fractions of each fund. Diagnostics, not advice.